Post-earnings recap
Reported
Thu, Feb 13, 2025
EPS actual
$-1.49
EPS est.
$-0.67
EPS surprise
-122.39%
1-day move
-5.42%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
IDEAYA Biosciences reported a significant loss per share, which contributed to a 5.42% decline in stock price. The lack of revenue figures and forward guidance may have raised concerns among investors. Overall, the company appears to be in a challenging position as it continues its research efforts without clear financial direction.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.49 | N/A | -122.39% |
| Revenue | N/A | N/A | N/A |
Management expressed a cautious approach, emphasizing the importance of their R&D initiatives. They did not provide any forward-looking guidance.
Management did not provide specific guidance for the upcoming quarters.
The company is focusing on its ongoing research and development efforts.